Journal of Symptoms and Signs is a peer-reviewed, open access journal that publishes original articles, review articles and case reports related to all aspects of symptom control and treatment. The aim of the Journal is to improve the level of learners in reading and understanding signs and symptoms today.
Journal of Symptoms and Signs is included in the following databases/resources:
|No announcements have been published.|
Vol 5, No 1 (2016)
Table of Contents
|Lixisenatide: A comprehensive review|
|Preethi Nalla, Stephen C Bain, Richard Chudleigh||1-7|
|Evolocumab in the treatment of hyperlipidaemia|
|Alemtuzumab in relapsing remitting multiple sclerosis (Efficacy and Safety)|
This work is licensed under a Creative Commons Attribution 3.0 License.
Articles featured on this website are opinion pieces composed by the authors, and not necessarily those of the editors or Journal of Symptoms and Signs. While every effort is made to ensure that the content of this website is accurate, the website is provided “as is” and Journal of Symptoms and Signs makes no representations or warranties in relation to the accuracy or completeness of the information found on it. While the content of this site is provided in good faith, we do not warrant that the information will be kept up to date, be true and not misleading, or that this site will always be available for use.
Journal of Symptoms and Signs